✦ LIBER ✦

PCN39 COST-UTILITY ANALYSIS IN A FRENCH SETTING OF ADJUVANT THERAPY WITH HERCEPTIN IN PATIENTS WITH HER-2 POSITIVE BREAST CANCER

✍ Scribed by F Fagnani; X Colin; P Arveux; C Coudray-Omnès

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN28 COST-UTILITY ANALYSIS IN A SPANISH

✍ C Polanco; M Carulla; X Badia; A Ramirez-Arellano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJU

✍ E Orlewska; T Pienkowski; K Drosik; M Gyldmark; R Aultman; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCN4 BUDGET IMPACT ANALYSIS OF ADJUVANT

✍ E Orlewska; R Aultman; M Krzakowski; T Pienkowski; K Drosik; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN17 COST-EFFECTIVENESS ANALYSIS OFTRAS

✍ M Correa; M Perdicaris; PRW Vernaglia; FM Da Cunha; MG Saggia; EA Santos; V Nasc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN57 COST-UTILITY ANALYSIS OF ADJUVANT

✍ TF Cheng 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCN102 COST EFFECTIVENESS ANALYSIS OF AD

✍ G Giuliani; JA Ray; A Urspruch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB